by TrN2016_SandWich | Sep 12, 2014 | News
Macmillan Coffee Morning Success! We had a fantastic time on Friday selling a range of homemade cakes and tickets for our Tombola stall, which did extremely well. Through our Coffee Morning and Just Giving page, we are delighted to have raised £327.80 for Macmillan...
by TrN2016_SandWich | Mar 17, 2014 | News
TRN are pleased to announce the occupation of offices at the Alderley Park BioHub site in Macclesfield. TRN will be joining other organisations, such as Gentronix Limited, Cyprotex Discovery Limited, BioNow and OncoTherics Limited at the Biohub.The TRN Alderley Park...
by TrN2016_SandWich | Aug 21, 2013 | News
Roger Butlin, Graham Maw, Tony Mete and Anna-Karin Tiden will be representing TRN and it’s experienced Medicinal Chemistry Team at the 17th RSC / SCI Medicinal Chemistry Symposium – Sunday to Wednesday, 8th-11th September 2013 at Churchill College, Cambridge,...
by TrN2016_SandWich | May 3, 2013 | News
Over 1,400 pupils from schools in East Kent got their hands dirty as they learned all about science and how it affects their everyday lives at the Discovery Park Science Jamboree. Mel Glossop of TRN put on an enchanting show demonstrating the wonders of dry ice using...
by TrN2016_SandWich | Apr 12, 2013 | News
The Research Network (TRN) is excited to announce that a new Therapeutic Team has joined the network – the Cardiovascular and Metabolic Disease Team. The Cardiovascular and Metabolic Disease group evolved from scientists of the AstraZeneca Alderley Park, UK and...
by TrN2016_SandWich | Mar 9, 2013 | News
Differentiating sodium-glucose co-transporter-2 inhibitors in development for the treatment of type 2 diabetes mellitus. Sodium-glucose co-transporter-2 (SGLT2) inhibitors are a novel class of agents for the treatment of type 2 diabetes mellitus (T2DM). By...
